A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Dickinson
Peter MacCallum Cancer Centre & Royal Melbourne Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Concord Repatriation General Hospital
Camperdown, New South Wales, Australia
- St Vincent'S Public Hospital Sydney
Darlinghurst, New South Wales, Australia
- Calvary Mater Newcastle
Newcastle, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Princess Alexander Hospital
Woolloongabba, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Box Hill Hospital
Box Hill, Victoria, Australia
- Barwon Health
Geelong, Victoria, Australia
- Cabrini Hospital
Malvern, Victoria, Australia
- Alfred Hospital
Melbourne, Victoria, Australia
- Epworth Healthcare
Melbourne, Victoria, Australia
- Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
- St Vincent'S Hospital Melbourne
Melbourne, Victoria, Australia
- Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jun 2021
- Primary completion
- 5 Dec 2023
- Completion
- 31 Jul 2025
- Last update posted
- 12 Aug 2024
- Registered enrollment
- 80
- Registry id
- NCT04914741
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.